This is not the latest version of MonQcle. Please visit
app.monqcle.com
to access and update legal dataset projects. For questions, please contact
monqcle@temple.edu.
F. A prescriber shall access the Prescription Monitoring Program prior to initially prescribing any Schedule II controlled dangerous substance to a patient for the treatment of non-cancer-related chronic or intractable pain.
see full law